Transaction with Affiliate Company
Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) on January 31, 2024, announced that its Board of Directors has authorized the following related-party transaction with an affiliated company.
Trademark License Agreement
- Grant trademark license to Samsung Medison
? Major Transaction Terms
| Transaction Item | License fee for use of trademark |
| Transaction Date | February 1, 2021 |
| Transaction Period | February 1, 2021-January 31, 2024 |
| Transaction Value | KRW 6.6 billion (total transaction value: KRW 6.6 billion) |
| Contract Type | - |
| Other information | - The cumulative transaction value up to end-2022 was less than the threshold for Board approval of KRW 5 billion. However, when adding the total value for 2023, the cumulative value exceeds the threshold, necessitating Board approval to collect the trademark license fees.
- The transaction date is the date the trade license agreement was made with Samsung Medison.
- The transaction value is an estimated cumulative amount for the transaction period (i.e., 3 years) and may change according to Samsung Medison's revenue.
* The license fee is set at 0.5% of Samsung Medison's revenue (excluding revenue not related to the use of trademark) and shall be paid every year during the transaction period. |
Other Information:
? Number of Independent Directors Present at the BOD Meeting: 6/6
? Attendance of Audit Committee: Y
? This disclosure is in accordance with the Korean Fair Trade Act, which mandates that a company must disclose
financial and real estate transactions in the event the value of such a transaction is greater or equal to KRW 5 billion
and the counterparty is a financial affiliate of the party required to make the disclosure.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.